Diabetes can be cured by following the Tayebat system without medication, illustrated by a patient who stopped insulin after 30 years of insulin use.

Original statement

جالي عيان راجل من تونس والراجل ده من بقىه 30 سنه بياخد انسولين بطل الانسولين من اربع شهور مشي على النظام شهرين بقى كويس

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Diabetes can be cured by following the Tayebat system without medication, illustrated by a patient who stopped insulin after 30 years of insulin use.

Origin

Source status

Video transcript (own words)

Attribution

Elawady (machine transcript)

Video

Dr Diaa Al Awady د ضياء العوضي is live! السيليوليت (Open source)

Published

11 October 2025

Timestamp

0:53:37 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)

Attribution uncertainty

Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.

Claimed mechanism

Removing harmful foods resolves the stress that raises glucose.

Claimed health effect

Diabetes cure

Population concerned

People with diabetes

Geographic restriction by Elawady

none found

Diverging source versions

Scientific assessment

Mostly false – Essential parts of the statement are not supported by the evidence or are strongly exaggerated.

Certainty of evidence: low – Further research is likely to change the assessment considerably.

1. What was claimed?

Diet cures diabetes, as shown by patients who stopped insulin on the system.

2. What is demonstrably correct?

DiRECT: remission (HbA1c <6.5% off all drugs) in 46% vs 4% at 12 months; 86% of those losing >=15 kg (I-FAST-12); 36% vs 3% at 24 months (I-FAST-13). The archive itself recommends diet and weight loss before insulin escalation (C-INS-11).

3. What is wrong or exaggerated?

DiRECT used total diet replacement (825-853 kcal/day) with structured support and excluded people on insulin and with diabetes >6 years; remission depended on weight loss, not on avoiding particular 'forbidden' foods (I-FAST-12). Remission mostly waned: at 5 years 10% vs 5% of the original randomised groups were in remission, 13% of the extension participants, and among those who had lost more than 10 kg remission fell from 78% at year 2 to 14% at year 5 (I-FAST-14). This does not support 'cure' or stopping insulin after 30 years. Type 1 diabetes cannot be cured by diet (C-INS-07). The Tayebat system has not been tested; the cases cited are not verifiable.

4. What remains unclear?

Whether the Tayebat dietary rules produce sufficient weight loss in practice.

5. Which studies support it?

I-FAST-12, I-FAST-13 (remission of early type 2 diabetes with major weight loss); partly I-FAST-14 (some long-term remission).

6. Which studies contradict it?

I-INS-03, I-ODD-16; I-FAST-14 (remission mostly not durable; people on insulin not studied).

7. What applies to Germany and Europe?

German guidance accepts remission through weight reduction as a goal in early type 2 diabetes.

8. What is known about Egypt?

Lifestyle-based remission programs are less established; supervision is needed when reducing drugs.

9. What practical conclusion is appropriate?

Early type 2 diabetes can go into remission with substantial weight loss under medical supervision; medicines are reduced step by step with monitoring. This does not apply to type 1 diabetes.

Assessment details

Rationale for certainty of evidence

Split: (a) remission of early type 2 diabetes through substantial weight loss is shown in an RCT (DiRECT: 46% at 1 year), but DiRECT excluded people on insulin and with diabetes for more than 6 years, and remission depended on weight loss, not on avoiding particular foods (I-FAST-12 to I-FAST-14). (b) Cure of type 1 diabetes or long-standing insulin-treated diabetes by diet is contradicted by guidelines (I-ODD-16). (c) The Tayebat system has not been tested. The claim as made, and the case used to illustrate it, fall under (b) and (c). Certainty is low because no study has tested the system itself.

Source quality

Own words; anecdotal cases.

Regional transferability

DiRECT conducted in UK primary care; transferability to Egypt plausible if weight loss is achieved.

Individual exceptions

Remission is most likely with short diabetes duration (<6 years), no insulin, and large sustained weight loss (>10-15 kg).

Regional scope of the claim

general (biological/medical)

Last reviewed

25 October 2026 provisional

In plain language

A British trial showed that almost half of people with recent type 2 diabetes who lost a lot of weight could stop all diabetes medicines for at least a year. Some kept this for five years. This worked through weight loss, under medical supervision. It does not apply to type 1 diabetes, and the specific Tayebat diet has never been tested.

Studies on this claim

Regional context

Germany / EU

German guidance accepts remission through weight reduction as a goal in early type 2 diabetes.

Egypt

Lifestyle-based remission programs are less established; supervision is needed when reducing drugs.

• Food-safety governance and official controls
• Import controls and the meaning of RASFF notifications for Egyptian products

What applies in my country?

General scientific assessment

Mostly false Early type 2 diabetes can go into remission with substantial weight loss, but the claim that the Tayebat system cures diabetes, including long-standing insulin-treated diabetes, is not supported.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

1. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.. Lean ME et al.. Lancet 2018 · PMID 29221645 · DOI 10.1016/S0140-6736(17)33102-1
2. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.. Lean MEJ et al.. Lancet Diabetes Endocrinol 2019 · PMID 30852132 · DOI 10.1016/S2213-8587(19)30068-3
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.. Diabetes Control and Complications Trial Research Group; Nathan DM et al.. N Engl J Med 1993 · PMID 8366922 · DOI 10.1056/NEJM199309303291401
4. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care 2026 · PMID 41358900 · DOI 10.2337/dc26-S009
5. 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study.. Lean ME et al.. Lancet Diabetes Endocrinol 2024 · PMID 38423026 · DOI 10.1016/S2213-8587(23)00385-6